drugset / Trial / NCT00083681
DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this investigational trial is to find out how well patients respond and how long their response lasts when treated with a four day chemotherapy regimen involving dexamethasone, cytoxan, etoposide, and cisplatinum, or DCEP with or without thalidomide. Another purpose is to find out what kind of side effects patients will experience.
Timeline
- Start
- 1998-06
- Primary completion
- —
- Completion
- 2005-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thalidomide | Other / unclassified | — | — |
| Background | Cisplatin | Other / unclassified | — | Intravenous |
| Background | Cyclophosphamide | Other / unclassified | — | Intravenous |
| Background | Dexamethasone | Small molecule | — | — |
| Background | Etoposide | Small molecule | — | Intravenous |
| Background | G-CSF | Unknown | — | Subcutaneous |